Sell Recommendation by Simon Herrmann, wise-owl.com

As found in "The Bull". Go half way down the article.

Simon Hermann, wise-owl.com

http://www.thebull.com.au/premium/a/58757-18-share-tips---14-march-2016.html

This is what he said about Acrux:

"Sales in 2015 of its flagship product Axiron, a testosterone replacement therapy, missed our expectations. We believe future sales may not meet our targets. We advised to sell in 2015 and retain our advice. While ACR may present a speculative opportunity, we would want to see more encouraging data and a technical reversal of its stock before upgrading our view."

I should not be bashing this stock. I wish I could think of a counter positive argument. As @mwilson25 said: what are the management saying? Actually what are they doing? Can anyone can anything that will counter what Simon Hermann. I do not want "Simon is a complete $#@$#@$" or "Simon is an absolute genius, etc etc". He is a professional and he is entitled to promote his opinion. I just want a positive counter argument.